Abstract
In this issue of Blood, Bartel and colleagues report the independent predictive value of the PET/CT and of the FDG suppression before transplantation in newly diagnosed myeloma patients who were treated using the TT3 regimen.
Cite
CITATION STYLE
APA
Dimopoulos, M. A., Moulopoulos, L. A., & Terpos, E. (2009). A new pet for myeloma. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2009-06-224196
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free